What are the typical presentation, diagnostic work‑up, and definitive treatment options for Hirschsprung disease in newborns and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hirschsprung Disease: Clinical Presentation, Diagnosis, and Management

Clinical Presentation

Newborns with delayed passage of first meconium beyond 24-48 hours of life, abdominal distension, and bilious vomiting should be immediately evaluated for Hirschsprung disease. 1

Key Presenting Features:

  • Delayed meconium passage (>24-48 hours after birth) is the hallmark sign 1, 2
  • Bilious vomiting indicating functional distal obstruction 3, 1
  • Abdominal distension from proximal bowel dilatation 1, 2
  • Chronic constipation in cases presenting beyond the neonatal period 2

Critical Pitfall:

Bilious vomiting in a newborn is a surgical emergency until proven otherwise—midgut volvulus must be excluded immediately before pursuing other diagnoses. 4 While Hirschsprung disease causes functional obstruction, malrotation with volvulus is immediately life-threatening and requires urgent surgical intervention. 3

Diagnostic Work-Up

Step 1: Initial Imaging

Plain abdominal radiographs should be obtained first to evaluate for bowel obstruction patterns and guide subsequent imaging. 1, 3 This helps differentiate proximal versus distal obstruction and identifies concerning patterns requiring immediate surgical consultation.

Step 2: Contrast Enema

Contrast enema is the primary screening tool with 80% sensitivity for detecting the transition zone between dilated proximal bowel and narrowed distal aganglionic segment. 1 However, this test has a 20% false-negative rate and should be considered a screening tool only, not definitive for excluding Hirschsprung disease. 1

Step 3: Definitive Diagnosis

Rectal biopsy is required for definitive diagnosis by demonstrating absence of ganglion cells in the myenteric and submucosal plexuses of the affected bowel segment. 4, 5, 2 This is the gold standard and must be performed to confirm the diagnosis before surgical intervention.

Immediate Management

Stabilization Protocol:

  • NPO status (nothing by mouth) 1
  • Intravenous fluid resuscitation to correct dehydration and electrolyte abnormalities 1
  • Nasogastric tube decompression to relieve proximal bowel distension 1
  • Immediate pediatric surgical consultation for any neonate with bilious vomiting 1

Associated Conditions and Screening

Screen all confirmed Hirschsprung disease patients for associated syndromes, particularly:

  • Congenital central hypoventilation syndrome (CCHS) in patients with PHOX2B mutations 1, 6
  • Trisomy 21 (Down syndrome) 2
  • Mowat-Wilson syndrome 2
  • Shah-Waardenburg syndrome 2

The American Academy of Pediatrics recommends documenting any associated syndromes as part of the diagnostic evaluation. 6

Definitive Treatment

Surgical resection of the aganglionic bowel segment with pull-through of normally innervated intestine to the anus is the definitive treatment. 5, 7, 2

Surgical Approaches:

Three primary procedures are available—Swenson, Soave, and Duhamel procedures—which may include laparoscopically assisted approaches. 2 The choice depends on the length of aganglionic segment and surgeon expertise.

Post-Operative Considerations:

Even after successful surgery, patients may experience long-term complications requiring systematic evaluation:

  • Persistent obstructive symptoms 7, 2
  • Hirschsprung-associated enterocolitis (HAEC), which can occur pre- or post-operatively and carries significant morbidity and mortality 5, 2
  • Fecal incontinence or soiling 7, 2

Management of post-operative symptoms requires evaluation for anatomic, inflammatory, behavioral, or motility-related factors, potentially including examination under anesthesia, contrast studies, endoscopy, anal sphincter function testing, and colonic motility studies. 7

References

Guideline

Hirschsprung Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hirschsprung disease.

Nature reviews. Disease primers, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis for Newborn with Bilious Vomiting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hirschsprung's disease associated enterocolitis: A comprehensive review.

World journal of clinical pediatrics, 2023

Guideline

Hirschsprung Disease Diagnosis and Associated Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hirschsprung's disease. Management.

Alimentary pharmacology & therapeutics, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.